May 13, 2026 10:39 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Vijay-led TVK wins Tamil Nadu floor test as AIADMK split plays out | Congress veteran Sonia Gandhi admitted to Medanta Hospital in Gurugram | PM Modi halves convoy size after austerity call | Mulayam Singh's younger son Prateek Yadav dies at 38 | Protests erupt in Delhi after NEET UG 2026 cancellation over alleged paper leak | AIADMK cracks widen after Tamil Nadu defeat; faction backs Vijay-led TVK government | Himanta Biswa Sarma takes oath as Assam CM for second term after BJP’s landslide win | Bengali rights activist Garga Chatterjee arrested over alleged provocative remarks ahead of assembly polls | No return to full WFH yet: IT firms unlikely to change hybrid work model despite PM Modi’s appeal | Suvendu Adhikari Cabinet clears BSF land transfer, census rollout, Ayushman Bharat in Bengal
Adar Poonawalla
Image: Adar Poonawalla Instagram page

The news of rising COVID cases coming out of China is concerning: SII CEO Adar Poonawalla

| @indiablooms | Dec 21, 2022, at 08:42 pm

Mumbai: Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday expressed concern over the rising COVID-19 cases in China and said the issue is 'concerning'.

"The news of rising COVID cases coming out of China is concerning, we need not panic given our excellent vaccination coverage and track record," he tweeted.

He said people should continue following the guidelines issued by the Indian government to combat COVID-19.

"We must continue to trust and follow the guidelines set by the Government of India and @MoHFW_INDIA," he said.

Adar  Poonawalla is the CEO of  Serum Institute of India which manufactures Covishield COVID-19 vaccine.

China is witnessing a rise in COVID-19 cases in recent days.

Analysis by Airfinity shows between 1.3 and 2.1 million lives could be at risk if China lifts its zero-COVID policy given low vaccination and booster rates as well as a lack of hybrid immunity.

Airfinity’s risk analysis uses cumulative peak cases and deaths from Hong Kong's BA.1 wave as a proxy for mainland China.

Hong Kong took a zero-COVID approach for the first two years of the pandemic.

Therefore, when the more transmissible Omicron BA.1 sublineage hit back in February, population immunity from infection was low.

This, combined with a low vaccine coverage, led to a huge wave of both infections and deaths, especially amongst the elderly.

Mainland China has very low levels of immunity across its population.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.